MUMBAI, Baltimore, May 31, 2017 /PRNewswire/ -- Today, Pharma Major Lupin Limited announced a partnership between its American subsidiary, Lupin Pharmaceuticals, Inc. (Lupin) and Albertsons Companies, ...

Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today ...

BALTIMORE, Aug. 16, 2023 /PRNewswire/ -- Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin) today announced the launch of Tiotropium ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...

Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals for the commercialization of tiotropium dry powder inhaler, 18 mcg/capsule, in the Chinese market, for the treatment ...

It took four tries over four years, but Perrigo has finally gotten over the finish line with its generic of Teva’s tricky-to-make ProAir HFA inhaler for chronic obstructive pulmonary disease and ...

Lupin jumped 6.75% to Rs 1108. The stock rose as much as 7.39% at the day's high at Rs 1114.65 today, which is also 52-week high for the counter. Cipla surged 5.84% to Rs 796. The scrip jumped as much ...